Replies to post #131 on Ardelyx Inc (ARDX)

[Whalatane]

Yes , there will definitely be some patients that benefit ... from the 2 in 1 benefit (lowering phosphorous levels and less constipation )
The trick is the transition period .

They do not want to stop the dialysis machines if suddenly someone wants to have a “ bowel movement “ .

So they may try and separate out those willing to be screened and use a commode ( if necessary ) while staying hooked up to the dialysis machine

Once this drug is approved they will definitely be exploring ways to make it work and in which patients .

Just don’t expect the head Nephrologist to attend a conference and come back and command every dialysis patient be on the drug
Look at the roll out of Valtessa for hyper kalemia ( high potassium ) .
It took a year after approval before the nephrologists my wife works with .... began widely using it
That was a far easy drug to transition to
Kiwi